CDH2 and neoplasm: Our studies of TN breast cancer cases (n = 6) obtained pre- and post- neoadjuvant chemotherapy treatment demonstrate that most patients exhibit an increased percentage of cell surface pro-N-cadherin-positive tumor cells post-treatment compared to pre-treatment (Table 1), validating our in vitro findings.